Cart (0)
  • No items in cart.
Total
$0
There is a technical issue about last added item. You can click "Report to us" button to let us know and we resolve the issue and return back to you or you can continue without last item via click to continue button.
Home
Content
Tour
eLibrary
Store
Search book title
Filters:
FORMAT
BOOKS
All Books
PACKAGES
All Packages
EDITION
to
PUBLISHER
AABC
(1)
AAMI
(338)
ACI
(589)
AECDAILY
(599)
AISC
(55)
ASA
(234)
ASCE
(1006)
ASHRAE
(696)
ASME
(2183)
ASSE
(117)
ASTM
(95207)
AWC
(63)
AWWA
(575)
BHMA
(124)
BICSI
(33)
BIFMA
(21)
BOMA
(20)
BSI
(95735)
CHD
(3)
CRSI
(17)
IAHSS
(1)
IAPMO
(374)
ICC
(324)
IEEE
(6938)
IES
(241)
ISEA
(21)
Joint Commission
(184)
Joint Commission Int.
(1)
NETA
(6)
NFPA
(1667)
TCNA
(18)
TMS
(19)
USGBC
(28)
WILEY
(4)
 
AR
(6)
AZ
(7)
CA
(115)
CT
(3)
FL
(57)
ID
(5)
IL
(5)
IN
(1)
KY
(1)
LA
(2)
MI
(25)
MN
(27)
NC
(27)
NJ
(13)
NY
(61)
OH
(24)
OR
(22)
PA
(7)
RI
(8)
SC
(20)
SD
(1)
TX
(3)
VA
(50)
VT
(6)
WA
(33)
CONTENT TYPE
 Act
 Admin Code
 Announcements
 Bill
 Book
 CADD File
 CAN
 CEU
 Charter
 Checklist
 City Code
 Code
 Commentary
 Comprehensive Plan
 Conference Paper
 County Code
 Course
 DHS Documents
 Document
 Errata
 Executive Regulation
 Federal Guideline
 Firm Content
 Guideline
 Handbook
 Interpretation
 Journal
 Land Use and Development
 Law
 Legislative Rule
 Local Amendment
 Local Code
 Local Document
 Local Regulation
 Local Standards
 Manual
 Model Code
 Model Standard
 Notice
 Ordinance
 Other
 Paperback
 PASS
 Periodicals
 PIN
 Plan
 Policy
 Product
 Product - Data Sheet
 Program
 Provisions
 Requirements
 Revisions
 Rules & Regulations
 Standards
 State Amendment
 State Code
 State Manual
 State Plan
 State Standards
 Statute
 Study Guide
 Supplement
 Sustainability
 Technical Bulletin
 All
  • BSI
    PAS 83:2012 Developing human cells for clinical applications in the European Union and the United States of America. Guide
    Edition: 2012
    $151.82
    / user per year

Description of PAS 83:2012 2012

This Publicly Available Specification (PAS) gives guidance by providing a quick reference source, to increase clarity for users on the requirements needed for exploitation of cell therapy products. The main focus of this PAS are cell based medicinal products (CBMPs) that are regulated as advanced therapy medicinal products (ATMP) in the EU and biologics (351 HCT/P) in the US. However, for completeness aspects of minimally manipulated, homologous use products (also known as 361 HCT/P in the US) are also covered.

This PAS will act as a guide to point users in the direction of the relevant EU and US legislation, guidance documents, pharmacopoeial chapters and monographs.

NOTE 1 Since the implementation of EU Directives varies between Member States it is not possible to provide specific national details of how legislation is enacted around the EU.

NOTE 2 Where national differences exist this will be indicated in the text.

This PAS is intended for use by organizations and individuals with an interest in the development of human cells for clinical applications including academic groups, small and medium sized enterprises (SMEs) and larger industrial manufacturers and the general public.

For researchers new to the field, this PAS will give an appreciation of the level of regulation, guidance and associated quality issues that apply to cell therapy products.

This PAS does not cover:

  • solid organ transplantation or blood transfusions;
  • blood products (e.g. serum, plasma, erythrocytes and platelets);
  • xenogeneic products and xenogeneic feeder cells, although much of the text will be broadly applicable;
  • combination products, although the text will still be applicable to the cellular component, other requirements will also apply;
  • tissue and cell products regulated in the US as devices (e.g. requiring PMA), although much of the text will be broadly applicable to the cellular component, other requirements will also apply;
  • genetically modified cell or tissues products, although the text will still be applicable to the cellular component other requirements will also apply;

but for clarity, their relationship to the overall process map is included where useful.



Standard NumberPAS 83:2012
TitleDeveloping human cells for clinical applications in the European Union and the United States of America. Guide
StatusWithdrawn
Publication Date2012-06-13
Withdrawn Date2022-03-21
ReplacesPAS 83:2006
DescriptorsTherapeutics, Standardization, Regulations, Diagnosis (medical), Cells (biology), Clinical medicine
ICS11.020.20 Medical science
CommitteeZZ/1
ISBN978 0 580 71052 0
PublisherBSI
Pages72

About BSI

BSI Group, also known as the British Standards Institution is the national standards body of the United Kingdom. BSI produces technical standards on a wide range of products and services and also supplies certification and standards-related services to businesses.
GROUPS
X